Valuation: BioHarvest Sciences Inc.

Market Cap 40.8M 35.36M 33.36M 30.27M 56.78M 3.91B 57.19M 398M 154M 1.98B 153M 150M 6.31B P/E 2026 *
-3.41x
P/E 2027 * -5.37x
Enterprise Value 40.8M 35.36M 33.36M 30.27M 56.78M 3.91B 57.19M 398M 154M 1.98B 153M 150M 6.31B EV / Sales 2026 *
1.09x
EV / Sales 2027 * 0.82x
Free-Float
85.23%
Yield 2026 *
-
Yield 2027 * -
1 day-2.70%
1 week-1.10%
Current month-5.76%
1 month-13.04%
3 months-43.75%
6 months-56.63%
Current year-65.32%
1 week 1.8
Extreme 1.8
1.93
1 month 1.8
Extreme 1.8
2.63
Current year 1.8
Extreme 1.8
6.15
1 year 1.8
Extreme 1.8
12.8
3 years 0
Extreme 0.0011
12.8
5 years 0
Extreme 0.0011
17.5
10 years 0
Extreme 0.0011
67.9
Manager TitleAgeSince
Chief Executive Officer 68 2026-04-28
Director of Finance/CFO - 2024-10-27
Chief Operating Officer 65 2023-04-18
Director TitleAgeSince
Chairman 68 2018-09-26
Director/Board Member 67 2018-09-26
Director/Board Member 84 2019-02-06
Date Insider Type Main position Quantity % Market Cap. Importance
3/16/26 Option 35,049 0.1547%
3/16/26 Other

Chief Operating Officer

0 0%
3/16/26 Option

Chief Executive Officer

43,841 0.1935%
Change 5-day change 1-year change 3-year change Capi.($)
-2.70%-1.10%-79.57%-63.00% 41.94M
+0.71%+0.38%-13.95%-4.93% 13.4B
+0.73%-2.48%-33.00%-56.61% 4.78B
+1.37%-1.67%-4.54%-5.49% 4.36B
+1.25%-2.41%-10.58%-30.85% 3.78B
+0.29%-2.42%-25.45%+0.67% 3.43B
+2.46%-1.28%-1.97%-2.46% 3.41B
-0.07%-4.17%-13.78%+3.39% 3.12B
+1.11%-1.28%-23.77%-17.59% 2.27B
+0.05%-2.81%-29.76%-20.30% 1.63B
Average +0.52%-1.98%-23.64%-19.72% 4.02B
Weighted average by Cap. +0.88%-1.77%-16.10%-13.64%

Financials

2026 *2027 *
Net sales 37.42M 32.42M 30.6M 27.76M 52.07M 3.59B 52.45M 365M 141M 1.82B 141M 137M 5.78B 49.59M 42.97M 40.55M 36.79M 69.01M 4.75B 69.51M 484M 187M 2.41B 186M 182M 7.67B
Net income -12.02M -10.41M -9.83M -8.92M -16.73M -1.15B -16.85M -117M -45.23M -584M -45.14M -44.15M -1.86B -7.65M -6.63M -6.25M -5.67M -10.64M -733M -10.72M -74.69M -28.78M -372M -28.73M -28.09M -1.18B
Net Debt - -
Logo BioHarvest Sciences Inc.
BioHarvest Sciences Inc. is a Canada-based botanical synthesis company. The Company leverages its technology platform to grow plant-based compounds, without the need to grow the underlying plant. It is leveraging its botanical synthesis technology to develop science-based therapeutic solutions within two major business verticals; as a contract development and manufacturing organization (CDMO) on behalf of customers seeking plant-based compounds, and as a creator of nutraceutical health and wellness products, which include dietary supplements. It delivers phytochemicals such as age-defying antioxidants and polyphenols used for wellness. Its product pipeline is focused on polyphenols, which include grape cells, olive cells, and pomegranate cells. Its process involves selecting the specific plant cells that can create the targeted ingredients. It offers VINIA, which is a nutraceutical containing the entire matrix of polyphenols contained in red grapes, including Piceid resveratrol.
Employees
89
Date Price Change Volume
26-09-14 US$1.800 -2.70% 13,055
26-09-11 US$1.850 -1.07% 28,347
26-09-10 US$1.870 +3.89% 13,761
26-09-09 US$1.800 -0.55% 36,810
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.800USD
Average target price
10.50USD
Spread / Average Target
+483.33%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BHST Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!